

Patient Based Evidence: Using Patient Reported Outcomes Measures (PROMs)
14
August
2020
Webinars for patient groups wanting to know about Patient Reported Outcome Measures (PROMs) research for reimbursement decisions
The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about Patient Reported Outcome Measures (PROMs) research for reimbursement decisions in Australia, especially PBAC and MSAC.
Including:
- What is PROMS research and what can it do? (Prof Rachel Morton, The University of Sydney)
- How and why NeuroEndocrine Cancer Australia uses PROMs research (Simone Leyden, NeuroEndocrine Cancer Australia. CEO)
- Time for your questions
This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:
Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi
Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda
Ongoing inkind support: CaPPRe; Rare Cancers Australia
And the generosity of all speakers who have given their time for free.